OMNICARE INC (NYSE: OCR)





$25.00 0.00 (0.00%)
Real-time 12:00:00 AM ET
Turn On
KEY STATS
52-Week High Price
29.57
52-Week Low Price
20.55
Avg Volume (3 Mo.)
1.00 M
Market Cap
2.98 B
P/E Ratio (TTM)
17.9
Diluted EPS (TTM)
2.51
Shares
119.34 M
Dividend Rate ($) / (%)
0.09/0.40
79%
21%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : -13% - OCR has underperformed the S&P 500 by 39%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
MEDCO HEALTH SOLUTIONS (MHS) $61.25 -  $1.08(1.79%)28.61 B
MCKESSON CORP (MCK) $58.75 -  $0.44(0.75%)15.70 B
CARDINAL HEALTH INC (CAH) $32.64 -  $0.38(1.18%)11.78 B
AMERISOURCE BERGEN CORP (ABC) $27.16 -  $0.21(0.78%)7.80 B
HERBALIFE (HLF) $37.87 -  $0.14(0.37%)2.34 B
NU SKIN ENTERPRISES (NUS) $26.13 -  $0.12(0.46%)1.64 B
GRUPO CASA SABA SA DE CV (SAB) $16.50 -  $0.00(0.00%)0.44 B
CHINA MEDICINE CORP (CHME) $3.48 -  $0.08(2.35%)0.05 B
MIT HOLDING INC (MITD) $0.05 -  $0.00(0.00%)0.00 B
AMEXDRUG CORP (AXRX) $0.13 -  $0.00(0.00%)0.02 B
STOCK ANALYSIS
Stock Analysis
Best Mid Caps In 2010 (KNM, JEC, OCR, UNM, JNJ)
A look at four mid caps that should outperform the market in 2010.
Stock Analysis
Four Stocks From The Heartland (FRPT, BHE, STE, BK, JNJ, BAC, TD)
If Bill Nasgovitz likes these stocks, you should too. This is the last of the Core Fore investing articles.
OCR RELATED HEADLINES
arrow
DOJ Suit Not The First For J&J Drug
Complaint alleges kickbacks for the sale of Risperdal, not the first time the drug has sparked litigation.

Forbes.com 1/15/2010
arrow
Best Mid Caps In 2010 (KNM, JEC, OCR, UNM, JNJ)
A look at four mid caps that should outperform the market in 2010.

at Investopedia Advisor 1/6/2010
arrow
Four Stocks From The Heartland (FRPT, BHE, STE, BK, JNJ, BAC, TD)
If Bill Nasgovitz likes these stocks, you should too. This is the last of the Core Fore investing articles.

at Investopedia Advisor 11/20/2009
arrow
Streetwalker: Five Price-To-Sales Plays
We scan the market for companies looking cheap relative to sales.

Forbes.com 10/13/2009
arrow
Omnicare (OCR) NewsBite - One Of Today's Top Losers
Omnicare (OCR) leads the list of top losers so far today and is now at $22.55, down $4.68 (-17.19%) on volume of 12,621,931 shares traded. Over the last 52 weeks the stock has ranged from a low of $19.14 to a high of $32.78. Omnicare stock has been showing support around $26.66 and resistance in the $27.96 range. Technical...

At Market Intelligence Center 7/30/2009
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM2